Method for selecting medical and biochemical diagnostic tests using neural network-related applications

• US 20030004906A1
• Filed: 01/11/2002
• Published: 01/02/2003
• Est. Priority Date: 02/09/1996
• Status: Abandoned Application

• Current Assignee: Cytyc Corporation (Hologic Incorporated)
• Original Assignee: Cytyc Corporation (Hologic Incorporated)
• Inventors: Lapointe, Jerome, DeSieno, Duane
• Application Number:
  US10/043,356
• Publication Number:
  US 20030004906A1
• Time in Patent Office: Days
• US Class Current: 706/20
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 15/00 ICT specially adapted for medical reports, e.g. generation or transmission thereof
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems
• CPC Class Codes: G16H 50/70 for mining of medical data, e.g. analysing previous cases of other patients

Abstract

Computer systems and methods for diagnosing endometriosis and for assessing the risk of delivery within selected time period after performing a test to assess the rist of preterm delivery or before thirty-five weeks of gestation are provided.

Claims

1. A computer system, comprising a neural network or plurality thereof trained for diagnosing endometriosis.

2. A method for diagnosing endometriosis in a subject, comprising:

querying and examining the patient to assess the answers to at least three of the following questions;

past history of endometriosis, number of births, dysmenorrhea, age, pelvic pain, history of pelvic surgery, smoking and if yes, the number of packs/day, medication history, number of pregnancies, number of abortions, abnormal PAP smear/dysplasia, pregnancy hyperplasia, genital warts and diabetes; and

based upon the results of the answers determining whether the patient has endometriosis.

3. A computer system, comprising a neural network or plurality thereof trained for assessing the risk of delivery within a selected time period, wherein the time period is within seven or fourteen days of performing a biochemical test to measure fetal fibronectin in a sample from a pregnant subject or the time period is prior to thirty five weeks of gestation.

4. The system of claim 3, wherein the time period is within seven days of performing a biochemical test to measure fetal fibronectin.

5. The system of claim 3, wherein the time period is within or fourteen days of performing a biochemical test to measure fetal fibronectin.

6. The system of claim 3, wherein the time period is prior to thirty five weeks of gestation.